nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—Ramipril—type 1 diabetes mellitus	0.514	1	CrCrCtD
Solifenacin—CHRM2—type 1 diabetes mellitus	0.432	1	CbGaD
Solifenacin—Benazepril—ACE—type 1 diabetes mellitus	0.00114	0.518	CrCbGaD
Solifenacin—Mequitazine—CHRM2—type 1 diabetes mellitus	0.00106	0.482	CrCbGaD
Solifenacin—Drug interaction—Ramipril—type 1 diabetes mellitus	0.000635	0.0528	CcSEcCtD
Solifenacin—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.000589	0.049	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000453	0.0377	CcSEcCtD
Solifenacin—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.000451	0.0375	CcSEcCtD
Solifenacin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00045	0.0373	CcSEcCtD
Solifenacin—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000395	0.0328	CcSEcCtD
Solifenacin—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000391	0.0325	CcSEcCtD
Solifenacin—Influenza—Ramipril—type 1 diabetes mellitus	0.00037	0.0307	CcSEcCtD
Solifenacin—Renal failure—Ramipril—type 1 diabetes mellitus	0.000324	0.0269	CcSEcCtD
Solifenacin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00032	0.0266	CcSEcCtD
Solifenacin—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000312	0.0259	CcSEcCtD
Solifenacin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000292	0.0242	CcSEcCtD
Solifenacin—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000291	0.0242	CcSEcCtD
Solifenacin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00028	0.0232	CcSEcCtD
Solifenacin—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000267	0.0222	CcSEcCtD
Solifenacin—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000267	0.0222	CcSEcCtD
Solifenacin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000259	0.0215	CcSEcCtD
Solifenacin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000258	0.0214	CcSEcCtD
Solifenacin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000252	0.021	CcSEcCtD
Solifenacin—Angioedema—Ramipril—type 1 diabetes mellitus	0.000235	0.0196	CcSEcCtD
Solifenacin—Palpitations—Ramipril—type 1 diabetes mellitus	0.000228	0.0189	CcSEcCtD
Solifenacin—Cough—Ramipril—type 1 diabetes mellitus	0.000225	0.0187	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000218	0.0181	CcSEcCtD
Solifenacin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000215	0.0178	CcSEcCtD
Solifenacin—Confusional state—Ramipril—type 1 diabetes mellitus	0.000212	0.0176	CcSEcCtD
Solifenacin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00021	0.0175	CcSEcCtD
Solifenacin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000206	0.0171	CcSEcCtD
Solifenacin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000205	0.017	CcSEcCtD
Solifenacin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000204	0.017	CcSEcCtD
Solifenacin—Somnolence—Ramipril—type 1 diabetes mellitus	0.000187	0.0155	CcSEcCtD
Solifenacin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000185	0.0154	CcSEcCtD
Solifenacin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000183	0.0152	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000182	0.0151	CcSEcCtD
Solifenacin—Fatigue—Ramipril—type 1 diabetes mellitus	0.000181	0.0151	CcSEcCtD
Solifenacin—Constipation—Ramipril—type 1 diabetes mellitus	0.00018	0.0149	CcSEcCtD
Solifenacin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000173	0.0144	CcSEcCtD
Solifenacin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000172	0.0143	CcSEcCtD
Solifenacin—Urticaria—Ramipril—type 1 diabetes mellitus	0.000167	0.0139	CcSEcCtD
Solifenacin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000166	0.0138	CcSEcCtD
Solifenacin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000155	0.0129	CcSEcCtD
Solifenacin—Asthenia—Ramipril—type 1 diabetes mellitus	0.000151	0.0125	CcSEcCtD
Solifenacin—Pruritus—Ramipril—type 1 diabetes mellitus	0.000149	0.0124	CcSEcCtD
Solifenacin—Dizziness—Ramipril—type 1 diabetes mellitus	0.000139	0.0116	CcSEcCtD
Solifenacin—Vomiting—Ramipril—type 1 diabetes mellitus	0.000134	0.0111	CcSEcCtD
Solifenacin—Rash—Ramipril—type 1 diabetes mellitus	0.000133	0.011	CcSEcCtD
Solifenacin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000132	0.011	CcSEcCtD
Solifenacin—Headache—Ramipril—type 1 diabetes mellitus	0.000132	0.0109	CcSEcCtD
Solifenacin—Nausea—Ramipril—type 1 diabetes mellitus	0.000125	0.0104	CcSEcCtD
Solifenacin—CHRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.25e-05	0.000566	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.24e-05	0.000564	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—SST—type 1 diabetes mellitus	2.23e-05	0.000561	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.22e-05	0.000559	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	2.2e-05	0.000555	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.19e-05	0.000551	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.16e-05	0.000543	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.13e-05	0.000536	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.1e-05	0.000528	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—KCNJ11—type 1 diabetes mellitus	2.08e-05	0.000525	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.07e-05	0.00052	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.06e-05	0.000518	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	2.05e-05	0.000516	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.05e-05	0.000515	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.05e-05	0.000515	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—SST—type 1 diabetes mellitus	2.04e-05	0.000515	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	2.04e-05	0.000514	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.04e-05	0.000513	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	2.04e-05	0.000512	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—SST—type 1 diabetes mellitus	2.02e-05	0.00051	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	2.02e-05	0.000508	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	2.02e-05	0.000507	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	2.01e-05	0.000507	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	2.01e-05	0.000507	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GCG—type 1 diabetes mellitus	2.01e-05	0.000505	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.99e-05	0.0005	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	1.98e-05	0.000498	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.97e-05	0.000497	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.96e-05	0.000493	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.96e-05	0.000493	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.96e-05	0.000493	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.94e-05	0.000488	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.93e-05	0.000486	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.93e-05	0.000486	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.91e-05	0.000482	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.88e-05	0.000474	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.88e-05	0.000473	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.88e-05	0.000472	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.88e-05	0.000472	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.87e-05	0.000471	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.86e-05	0.000468	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.85e-05	0.000466	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.85e-05	0.000466	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.83e-05	0.00046	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.82e-05	0.000459	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.8e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SST—type 1 diabetes mellitus	1.8e-05	0.000452	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.79e-05	0.00045	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	1.77e-05	0.000445	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GAL—type 1 diabetes mellitus	1.76e-05	0.000444	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.76e-05	0.000443	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ITPR3—type 1 diabetes mellitus	1.76e-05	0.000443	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.75e-05	0.000442	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.75e-05	0.00044	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.75e-05	0.00044	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GAL—type 1 diabetes mellitus	1.75e-05	0.000439	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.74e-05	0.000439	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.74e-05	0.000439	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.74e-05	0.000437	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.73e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.73e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SST—type 1 diabetes mellitus	1.72e-05	0.000433	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.71e-05	0.000431	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.71e-05	0.00043	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.7e-05	0.000429	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.7e-05	0.000429	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.7e-05	0.000428	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.69e-05	0.000425	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.68e-05	0.000424	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—HBA1—type 1 diabetes mellitus	1.66e-05	0.000417	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOC3—type 1 diabetes mellitus	1.65e-05	0.000414	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.64e-05	0.000414	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.64e-05	0.000412	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	1.64e-05	0.000412	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTT1—type 1 diabetes mellitus	1.62e-05	0.000407	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GCG—type 1 diabetes mellitus	1.6e-05	0.000403	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	1.55e-05	0.000391	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	1.55e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.54e-05	0.000388	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GCG—type 1 diabetes mellitus	1.53e-05	0.000386	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.5e-05	0.000377	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.49e-05	0.000376	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.48e-05	0.000372	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.48e-05	0.000371	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.47e-05	0.00037	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.46e-05	0.000367	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.46e-05	0.000366	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.45e-05	0.000365	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.44e-05	0.000362	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.43e-05	0.000361	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.43e-05	0.000361	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.43e-05	0.00036	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.43e-05	0.00036	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.42e-05	0.000356	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.39e-05	0.00035	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.38e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.38e-05	0.000347	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.38e-05	0.000347	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.38e-05	0.000346	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.38e-05	0.000346	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.37e-05	0.000345	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.36e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.36e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.36e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.36e-05	0.000341	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.32e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.32e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CD86—type 1 diabetes mellitus	1.31e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.3e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.3e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.3e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.3e-05	0.000327	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.3e-05	0.000327	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	1.29e-05	0.000324	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.29e-05	0.000324	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	1.26e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	1.25e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.25e-05	0.000314	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.24e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	1.21e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	1.21e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.21e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.2e-05	0.000303	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	1.2e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.19e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.19e-05	0.0003	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	1.19e-05	0.000299	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.19e-05	0.000299	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.18e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.16e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.14e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.13e-05	0.000285	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.13e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.11e-05	0.000279	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.09e-05	0.000275	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	1.09e-05	0.000274	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.08e-05	0.000273	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.08e-05	0.000272	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.08e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.07e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.04e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.04e-05	0.000261	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.03e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.03e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.01e-05	0.000254	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.01e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.01e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.97e-06	0.000251	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.94e-06	0.00025	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	9.53e-06	0.00024	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.18e-06	0.000231	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.15e-06	0.00023	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.14e-06	0.00023	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	9.12e-06	0.00023	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.11e-06	0.000229	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.06e-06	0.000228	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.03e-06	0.000227	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	9e-06	0.000227	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	8.8e-06	0.000222	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	8.78e-06	0.000221	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.71e-06	0.000219	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	8.69e-06	0.000219	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.66e-06	0.000218	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	8.62e-06	0.000217	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.41e-06	0.000212	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.38e-06	0.000211	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.35e-06	0.00021	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.34e-06	0.00021	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.33e-06	0.00021	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.3e-06	0.000209	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.3e-06	0.000209	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.25e-06	0.000208	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	8.15e-06	0.000205	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.04e-06	0.000202	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.94e-06	0.0002	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.91e-06	0.000199	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.89e-06	0.000199	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.84e-06	0.000197	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.81e-06	0.000197	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.78e-06	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.71e-06	0.000194	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.7e-06	0.000194	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.7e-06	0.000194	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.67e-06	0.000193	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.64e-06	0.000192	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.61e-06	0.000192	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.6e-06	0.000191	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.56e-06	0.00019	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.54e-06	0.00019	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—INS—type 1 diabetes mellitus	7.23e-06	0.000182	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	6.88e-06	0.000173	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.7e-06	0.000169	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	6.69e-06	0.000168	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.66e-06	0.000168	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	6.63e-06	0.000167	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	6.47e-06	0.000163	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	6.43e-06	0.000162	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.42e-06	0.000162	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.42e-06	0.000162	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	6.41e-06	0.000161	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	6.4e-06	0.000161	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.38e-06	0.00016	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	6.34e-06	0.00016	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.34e-06	0.00016	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	6.32e-06	0.000159	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	6.07e-06	0.000153	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	6.05e-06	0.000152	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	5.99e-06	0.000151	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.87e-06	0.000148	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.85e-06	0.000147	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.84e-06	0.000147	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.82e-06	0.000147	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.79e-06	0.000146	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.77e-06	0.000145	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.63e-06	0.000142	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.42e-06	0.000136	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.4e-06	0.000136	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.39e-06	0.000136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.35e-06	0.000135	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.32e-06	0.000134	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.31e-06	0.000134	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.25e-06	0.000132	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.12e-06	0.000129	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	5.03e-06	0.000127	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.9e-06	0.000123	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.52e-06	0.000114	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.51e-06	0.000114	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.5e-06	0.000113	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.5e-06	0.000113	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.49e-06	0.000113	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.47e-06	0.000113	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.46e-06	0.000112	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.45e-06	0.000112	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.43e-06	0.000112	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.26e-06	0.000107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.93e-06	9.9e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.8e-06	9.56e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.78e-06	9.53e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	3.77e-06	9.48e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.75e-06	9.43e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.45e-06	8.69e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.44e-06	8.66e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.41e-06	8.57e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.83e-06	7.12e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.65e-06	6.68e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.64e-06	6.65e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.62e-06	6.59e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.59e-06	6.53e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.48e-06	6.24e-05	CbGpPWpGaD
